Low Level of Advanced Glycation End Products in Serum of Patients with Allergic Rhinitis and Chronic Epstein-Barr Virus Infection at Different Stages of Virus Persistence

<div>Comparison of AGE level between a group of patients with allergic rhinitis groups and a control group, determined with immunochemical method (a), fluorescence measurement at 335/385 nm for pentosidine (b), and at 370/440 nm for total fluorescent AGE (c) of excitation/emission, respectively.</div>

Journal of Immunology Research

fig1

Figure 1

Figure 1: Low Level of Advanced Glycation End Products in Serum of Patients with Allergic Rhinitis and Chronic Epstein-Barr Virus Infection at Different Stages of Virus Persistence 

Figure 1 | Low Level of Advanced Glycation End Products in Serum of Patients with Allergic Rhinitis and Chronic Epstein-Barr Virus Infection at Different Stages of Virus Persistence 